Pharosyn
eDR22Effective DR: 22/100. Bottom 25%. Measured by StartupHub.ai. Median 68.Agent30Agent Readiness: 30/100. Below median. Measured by StartupHub.ai. Median 41.Pharosyn is an AI-powered competitive intelligence platform for biopharma, automating monitoring and strategic reporting from clinical, regulatory, and commercial data.
About
Pharosyn develops AI systems for the commercial departments of pharmaceutical companies. Their platform continuously tracks clinical, regulatory, and commercial data sources, including trial data, deals, hiring trends, and epidemiology, to produce strategic reports tailored to an organization's pipeline. This helps biopharma companies make quicker decisions on pricing, market access, and portfolios.
Key facts
At-a-glance profile data
- Website
- pharosyn.ai
- Headquarters
- London, United Kingdom
- Founded
- 2025
- Employees
- 6
- Total funding
- $3M (Seed)
- Business model
- B2B
Funding rounds
Tech stack
Detected on pharosyn.ai, last scanned 18 Sept 2026. Run your own scan
- Frontend
- Next.js, Tailwind CSS
- Hosting
- Railway
- Email provider
- Microsoft 365
Frequently asked
Is Pharosyn trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Pharosyn is 29 out of 100, based on site security posture and privacy practices.
How much funding has Pharosyn raised?
Pharosyn has raised a total of $3M in funding. The most recent round on record is Seed.
How many employees does Pharosyn have?
Pharosyn has approximately 6 people on record.